Emeraid

NEWS

Press Release — 2026.02.20

Back to News

Emeraid Completes Collaborative Clinical Data Analysis Project with Integrity Healthcare

2026.02.20Press Release
Emeraid Completes Collaborative Clinical Data Analysis Project with Integrity Healthcare

Emeraid, Inc., a University of Tokyo startup challenging the optimization and sustainability of the medical and healthcare industry through AI-DX using cutting-edge technologies including AI, and Integrity Healthcare, Inc. announced the start of a collaborative project in the pharmaceutical industry in December 2024. The companies have now announced the completion of the clinical data analysis undertaken as part of this collaborative project.

For inquiries about clinical data analysis or collaborative projects, please feel free to contact us.

About Integrity Healthcare, Inc.

A medical tech company creating the future of healthcare through the fusion of people and technology. They develop YaDoc — a disease management system utilizing technology, YaDoc Quick — an online medical consultation system, and Smart One Health — a PHR management system.

  • -Company: Integrity Healthcare, Inc.
  • -Founded: October 2009
  • -Representatives: Chairman Shinsuke Muto, President Ai Sonoda
  • -Business: Provision of disease management systems and online medical consultation systems utilizing technology
  • -Location: +SHIFT TSUKIJI 4F, 3-12-5 Tsukiji, Chuo-ku, Tokyo

About Emeraid, Inc.

Emeraid is a University of Tokyo venture company that upholds the philosophy of "A society where everyone can face 'living' head-on," aiming to optimize and sustain healthcare — the very infrastructure of life — through AI-DX. Leveraging domain knowledge and problem understanding specialized in the healthcare industry, combined with cutting-edge technology centered on AI, Emeraid creates future-oriented solutions for the complex challenges faced by medical institutions and companies.

Built on its proprietary Healthcare AI Platform "SUI" — a technology foundation developed through in-house R&D and medical research — the company provides a Solutions Business offering end-to-end support spanning AI, software, and hardware, from issue analysis to system development and operational improvement, as well as Medical Data Analytics grounded in bioinformatics and chemoinformatics for clinical research and trials.

  • -Company: Emeraid, Inc.
  • -Founded: February 2024
  • -Representative: CEO Rikuto Shima
  • -Location: Sobunkan Bldg. 3F, 6-25-14 Hongo, Bunkyo-ku, Tokyo